rs229587
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_001355436.2(SPTB):c.1316G>A(p.Ser439Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.356 in 1,613,916 control chromosomes in the GnomAD database, including 107,460 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001355436.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SPTB | NM_001355436.2 | c.1316G>A | p.Ser439Asn | missense_variant | 11/36 | ENST00000644917.1 | NP_001342365.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SPTB | ENST00000644917.1 | c.1316G>A | p.Ser439Asn | missense_variant | 11/36 | NM_001355436.2 | ENSP00000495909.1 | |||
SPTB | ENST00000389722.7 | c.1316G>A | p.Ser439Asn | missense_variant | 10/35 | 2 | ENSP00000374372.3 | |||
SPTB | ENST00000389720.4 | c.1316G>A | p.Ser439Asn | missense_variant | 11/32 | 5 | ENSP00000374370.4 |
Frequencies
GnomAD3 genomes AF: 0.424 AC: 64503AN: 151966Hom.: 15091 Cov.: 32
GnomAD3 exomes AF: 0.369 AC: 92811AN: 251462Hom.: 18247 AF XY: 0.373 AC XY: 50696AN XY: 135910
GnomAD4 exome AF: 0.348 AC: 509386AN: 1461832Hom.: 92342 Cov.: 62 AF XY: 0.353 AC XY: 256636AN XY: 727222
GnomAD4 genome AF: 0.425 AC: 64573AN: 152084Hom.: 15118 Cov.: 32 AF XY: 0.423 AC XY: 31472AN XY: 74322
ClinVar
Submissions by phenotype
not provided Benign:4
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 30, 2023 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 18, 2018 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Elliptocytosis Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Hereditary spherocytosis type 2 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Spherocytosis, Dominant Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at